Literature DB >> 31773045

Comparing 2 Monte Carlo Systems in Use for Proton Therapy Research.

Mark Newpower1,2, Jan Schuemann3, Radhe Mohan1, Harald Paganetti3, Uwe Titt1.   

Abstract

PURPOSE: Several Monte Carlo transport codes are available for medical physics users. To ensure confidence in the accuracy of the codes, they must be continually cross-validated. This study provides comparisons between MC2 and Tool for Particle Simulation (TOPAS) simulations, that is, between medical physics applications for Monte Carlo N-Particle Transport Code (MCNPX) and Geant4.
MATERIALS AND METHODS: Monte Carlo simulations were repeated with 2 wrapper codes: TOPAS (based on Geant4) and MC2 (based on MCNPX). Simulations increased in geometrical complexity from a monoenergetic beam incident on a water phantom, to a monoenergetic beam incident on a water phantom with a bone or tissue slab at various depths, to a spread-out Bragg peak incident on a voxelized computed tomography (CT) geometry. The CT geometry cases consisted of head and neck tissue and lung tissue. The results of the simulations were compared with one another through dose or energy deposition profiles, r 90 calculations, and γ-analyses.
RESULTS: Both codes gave very similar results with monoenergetic beams incident on a water phantom. Systematic differences were observed between MC2 and TOPAS simulations when using a lung or bone slab in a water phantom, particularly in the r 90 values, where TOPAS consistently calculated r 90 to be deeper by about 0.4%. When comparing the performance of the 2 codes in a CT geometry, the results were still very similar, exemplified by a 3-dimensional γ-analysis pass rate > 95% at the 2%-2-mm criterion for tissues from both head and neck and lung.
CONCLUSION: Differences between TOPAS and MC2 were minor and were not considered clinically relevant. ©Copyright 2019 The Author(s).

Entities:  

Keywords:  Monte Carlo simulations; intercomparison

Year:  2019        PMID: 31773045      PMCID: PMC6871627          DOI: 10.14338/IJPT-18-00043.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  23 in total

1.  Evaluation of the gamma dose distribution comparison method.

Authors:  Daniel A Low; James F Dempsey
Journal:  Med Phys       Date:  2003-09       Impact factor: 4.071

2.  Degradation of proton depth dose distributions attributable to microstructures in lung-equivalent material.

Authors:  Uwe Titt; Martin Sell; Jan Unkelbach; Mark Bangert; Dragan Mirkovic; Uwe Oelfke; Radhe Mohan
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

3.  Experimental test of Monte Carlo proton transport at grazing incidence in GEANT4, FLUKA and MCNPX.

Authors:  Peter Kimstrand; Nina Tilly; Anders Ahnesjö; Erik Traneus
Journal:  Phys Med Biol       Date:  2008-02-05       Impact factor: 3.609

4.  GATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy.

Authors:  S Jan; D Benoit; E Becheva; T Carlier; F Cassol; P Descourt; T Frisson; L Grevillot; L Guigues; L Maigne; C Morel; Y Perrot; N Rehfeld; D Sarrut; D R Schaart; S Stute; U Pietrzyk; D Visvikis; N Zahra; I Buvat
Journal:  Phys Med Biol       Date:  2011-01-20       Impact factor: 3.609

5.  TOPAS: an innovative proton Monte Carlo platform for research and clinical applications.

Authors:  J Perl; J Shin; J Schumann; B Faddegon; H Paganetti
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

6.  Uncertainties in planned dose due to the limited voxel size of the planning CT when treating lung tumors with proton therapy.

Authors:  Samuel España; Harald Paganetti
Journal:  Phys Med Biol       Date:  2011-05-31       Impact factor: 3.609

7.  Assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Proton Therapy.

Authors:  Jan Schuemann; Drosoula Giantsoudi; Clemens Grassberger; Maryam Moteabbed; Chul Hee Min; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-08       Impact factor: 7.038

8.  Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer.

Authors:  Agustinus J A J van de Schoot; Peter de Boer; Koen F Crama; Jorrit Visser; Lukas J A Stalpers; Coen R N Rasch; Arjan Bel
Journal:  Acta Oncol       Date:  2016-03-03       Impact factor: 4.089

9.  Quantification of proton dose calculation accuracy in the lung.

Authors:  Clemens Grassberger; Juliane Daartz; Stephen Dowdell; Thomas Ruggieri; Greg Sharp; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-11       Impact factor: 7.038

10.  Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.

Authors:  Shravan Kandula; Xiaorong Zhu; Adam S Garden; Michael Gillin; David I Rosenthal; Kie-Kian Ang; Radhe Mohan; Mayankkumar V Amin; John A Garcia; Richard Wu; Narayan Sahoo; Steven J Frank
Journal:  Med Dosim       Date:  2013-08-02       Impact factor: 1.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.